Cargando…
Editorial: Cardiorenal dysregulation in endocrine disorders: innovative mechanisms and therapeutic interventions
Autores principales: | Shawky, Noha M., Soliman, Eman, Abdel-Rahman, Abdel A., Rezq, Samar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486096/ https://www.ncbi.nlm.nih.gov/pubmed/37693912 http://dx.doi.org/10.3389/fphar.2023.1275919 |
Ejemplares similares
-
CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome
por: Zheng, Cankun, et al.
Publicado: (2022) -
miR-21, Mediator, and Potential Therapeutic Target in the Cardiorenal Syndrome
por: Huang, Cheng-Kai, et al.
Publicado: (2020) -
Nonsteroidal Mineralocorticoid Receptor Antagonist (Finerenone) in Cardiorenal Disease
por: Shah, Monarch, et al.
Publicado: (2023) -
Editorial: Innovation in ocular pharmacology
por: Gozzo, Lucia, et al.
Publicado: (2023) -
Syzygium aqueum: A Polyphenol- Rich Leaf Extract Exhibits Antioxidant, Hepatoprotective, Pain-Killing and Anti-inflammatory Activities in Animal Models
por: Sobeh, Mansour, et al.
Publicado: (2018)